ONDANSETRON (GR38032F) PLUS DEXAMETHASONE - EFFECTIVE ANTIEMETIC PROPHYLAXIS FOR PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY

被引：49
|
作者：
SMITH, DB
NEWLANDS, ES
SPRUYT, OW
BEGENT, RHJ
RUSTIN, GJS
MELLOR, B
BAGSHAWE, KD
机构：
[1] Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London
来源：
BRITISH JOURNAL OF CANCER | 1990年 / 61卷 / 02期
关键词：
D O I：
10.1038/bjc.1990.62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：323 / 324
页数：2
相关论文
共 50 条
  • [1] ONDANSETRON (GR38032F) - EFFECTIVE ANTIEMETIC PROPHYLAXIS FOR PATIENTS RECEIVING CARBOPLATIN CHEMOTHERAPY
    SMITH, DB
    RUSTIN, GJS
    HOWELL, N
    MCQUADE, BA
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 524 - 524
  • [2] ONDANSETRON (GR 38032F) - A NOVEL ANTIEMETIC EFFECTIVE IN PATIENTS RECEIVING A MULTIPLE-DAY REGIMEN OF CISPLATIN CHEMOTHERAPY
    HAINSWORTH, JD
    OMURA, GA
    KHOJASTEH, A
    BRYSON, JC
    FINN, AL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (04): : 336 - 340
  • [3] GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST, IS ANTIEMETIC IN PATIENTS RECEIVING CYTOTOXIC DRUGS
    CUNNINGHAM, D
    HAWTHORN, J
    POPLE, A
    GAZET, JC
    FORD, HT
    CHALLONER, T
    COOMBES, RC
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 217 - 217
  • [4] A randomised, double-blind, parallel-group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethasone with metoclopramide plus dexamethasone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapy
    duBois, A
    McKenna, CJ
    Andersson, H
    Lahousen, M
    Kitchener, H
    Pinter, T
    Capstick, V
    Wilkinson, JR
    ONCOLOGY, 1997, 54 (01) : 7 - 14
  • [5] CONTROL OF REFRACTORY, CHEMOTHERAPY-INDUCED EMESIS WITH THE SEROTONIN ANTAGONIST ONDANSETRON (GR38032F)
    CAMPORA, E
    VIDILI, G
    OLIVA, C
    ARDIZZONI, A
    ROSSO, R
    ONCOLOGY, 1991, 48 (05) : 403 - 405
  • [6] DOSE-RANGING EVALUATION OF THE SEROTONIN ANTAGONIST GR-C507/75 (GR38032F) WHEN USED AS AN ANTIEMETIC IN PATIENTS RECEIVING ANTICANCER CHEMOTHERAPY
    KRIS, MG
    GRALLA, RJ
    CLARK, RA
    TYSON, LB
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) : 659 - 662
  • [7] CORRELATION OF ANTIEMETIC EFFICACY AND SERUM LEVELS OF THE ANTISEROTONERGIC AGENT GR38032F
    GRUNBERG, SM
    GROSHEN, S
    ROBINSON, DC
    STEVENSON, L
    SANDERSON, PE
    CLINICAL RESEARCH, 1989, 37 (02): : A466 - A466
  • [8] THE ANTIEMETIC PROPERTIES OF THE 5HT3 ANTAGONIST, GR38032F
    BUNCE, KT
    STABLES, R
    GUNNING, SJ
    TYERS, MB
    ANDREWS, PLR
    BAILEY, HE
    HAWTHORNE, J
    COSTALL, B
    DOMENEY, AM
    NAYLOR, RJ
    TATTERSALL, FD
    GASTROENTEROLOGY, 1988, 94 (05) : A54 - A54
  • [9] THE EFFECTS OF ONDANSETRON (GR38032F) IN RATS AND MICE TREATED SUBCHRONICALLY WITH DIAZEPAM
    COSTALL, B
    JONES, BJ
    KELLY, ME
    NAYLOR, RJ
    OAKLEY, NR
    ONAIVI, ES
    TYERS, MB
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (04) : 769 - 778
  • [10] ANTIEMETIC PROPERTIES OF THE 5HT3 ANTAGONIST, GR38032F
    STABLES, R
    ANDREWS, PLR
    COSTALL, B
    GUNNING, SJ
    HAWTHORNE, J
    NAYLOR, RJ
    TATTERSALL, FD
    TYERS, MB
    ANTI-CANCER DRUG DESIGN, 1987, 2 (01): : 97 - 97
12345